Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of topical recombinant human acidic fibroblast growth factor for accelerated healing of fresh surgical wounds
CTR20210692Phase 3Active
- Sponsor
- Shanghai Tenry Pharmaceutical Co., Ltd.
- Start
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human acidic fibroblast growth factor in acute wound, Surgical wound, sponsored by Shanghai Tenry Pharmaceutical Co., Ltd.. Started Apr 2021; status: active.
02
Drugs
recombinant human acidic fibroblast growth factor
03
Conditions
acute woundSurgical wound
Beyond the preview
Go deeper on CTR20210692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210692.